These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32383556)

  • 1. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
    Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
    Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.
    Chatzopoulos K; Sotiriou S; Collins AR; Kartsidis P; Schmitt AC; Chen X; Khazaie K; Hinni ML; Ramsower CA; Zarka MA; Patel SH; Garcia JJ
    Head Neck Pathol; 2021 Jun; 15(2):509-522. PubMed ID: 33010009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 expression in tongue squamous cell carcinoma.
    Akisada N; Nishimoto K; Takao S; Gion Y; Marunaka H; Tachibana T; Makino T; Miki K; Akagi Y; Tsumura M; Toji T; Yoshino T; Nishizaki K; Orita Y; Sato Y
    Med Mol Morphol; 2021 Mar; 54(1):52-59. PubMed ID: 32699939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence.
    Naruse T; Yanamoto S; Okuyama K; Ohmori K; Tsuchihashi H; Furukawa K; Yamada SI; Umeda M
    Pathol Oncol Res; 2020 Apr; 26(2):735-742. PubMed ID: 30767115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3
    Zhao LL
    J Bioenerg Biomembr; 2020 Aug; 52(4):279-289. PubMed ID: 32594290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity enhances the response to neoadjuvant anti-PD1 therapy in oral tongue squamous cell carcinoma.
    Tan X; Li G; Deng H; Xiao G; Wang Y; Zhang C; Chen Y
    Cancer Med; 2024 Jun; 13(12):e7346. PubMed ID: 38923758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
    Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
    Troiano G; Rubini C; Togni L; Caponio VCA; Zhurakivska K; Santarelli A; Cirillo N; Lo Muzio L; Mascitti M
    Cancer Med; 2020 Nov; 9(22):8333-8344. PubMed ID: 33047888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
    Hu C; Tian S; Lin L; Zhang J; Ding H
    Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
    Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
    Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.
    Daroonpan P; Ouchi R; Zhang C; Nagai S; Nishii N; Kashima Y; Tsushima F; Harada H; Hamagaki M; Ikeda T; Aida J; Kaomongkolgit R; Azuma M
    Oral Oncol; 2023 Aug; 143():106458. PubMed ID: 37329869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
    Liu L; Wang X; Ge W
    Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of PD-L1 Expression in Tongue Cancer Development.
    Yoshida S; Nagatsuka H; Nakano K; Kogashiwa Y; Ebihara Y; Yano M; Yasuda M
    Int J Med Sci; 2018; 15(14):1723-1730. PubMed ID: 30588196
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
    Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
    Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer Prognosticator.
    Sieviläinen M; Wirsing AM; Hyytiäinen A; Almahmoudi R; Rodrigues P; Bjerkli IH; Åström P; Toppila-Salmi S; Paavonen T; Coletta RD; Hadler-Olsen E; Salo T; Al-Samadi A
    Head Neck Pathol; 2021 Jun; 15(2):469-478. PubMed ID: 32959211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Expression of PD-1 and PD-L1 In Head And Neck Squamous Cell Carcinoma And their Association With Nodal Metastasis: A Cross-Sectional Study.
    Malik IS; Asif M; Bashir N; Ara N; Rashid F; Din HU; Malik NS; Bashir A
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):467-473. PubMed ID: 35225458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4
    Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI
    Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.